India and Drugs Current Affairs - 2020
The Council of Scientific and Industrial Research (CSIR) and Central Drug Research Institute (CDRI) signed an agreement to develop new drugs and repurposing of drugs for India and for global markets. The team research work is also joined by Cipla.
What is Drug Repurposing?
Drug repurposing is identifying new uses of approved or investigational drugs. It is used to treat common and rare diseases. The main advantage of using repurposing drugs is its reduced development cost, shortened development timings and increased use of de-risked compounds.
Cipla association with the institutes
The association of Cipla with the institutes has its origin in 1942. Cipla has also worked with the institutes in formulating the famous drugs called chandonium iodide in 1995. The drug is used against neuro muscular blockers. The drug was a huge hit in Indian and global markets. The gugulipid drug used for treating hypolipidemic was also developed under such venture.
The CSIR having a pan-India presence is known for its research and development in S&T areas. It includes oceanography, space physics, drugs, biotechnology, etc. CSIR is currently implementing a mission “New CSIR for New India” to be completed by 2022. The vision of the mission is to enable innovation-driven industry and catalyze inclusive economic development.
The institute holds 84th rank among 4851 institutions in the world according to the Scimago institutions ranking world report.
Tags: Council of Scientific and Industrial Research (CSIR) • CSIR • Drugs • Health • India and Drugs
The Global Drugs Survey, a survey of recreational drug-use for the first time polled respondents from India. It found that more than any other nationalities, Indians are seeking help to reduce their alcohol intake which reflects awareness of abuse. GDS 2019 is the 8th annual report published by the organisation.
About Global Drug Survey (GDS)
- It is an independent research organisation based in London, United Kingdom (UK). It runs the largest global survey on recreational drug-use.
- It is basically an anonymised online survey which uses a detailed questionnaire to assess trends in self-reported harms and drug use among regular drug users and early adopters of new trends.
- Covers: Although it is not designed to determine the prevalence of drug behaviour in all the population of country but it throws light on prevalent stigmatized behaviours and health outcomes of that hidden population which is otherwise difficult to reach.
- Importance: It can be used to inform targeted interventions about outcomes of drug-use. It uses its data and expertise to create digital health applications delivering screening as well as brief interventions for alcohol and drugs. It also produces a range of drug education materials for health and legal professionals, the entertainment industry and the general public.
GDS 2019: Key Findings about India
- In comparison to respondents from other nationalities the Indians respondents are seeking help to reduce their drugs and alcohol intake.
- Survey Shows Indians Willingness: that 51% of respondents wanted to ‘drink less’ in the following year and while only about 43% of Indians reported using cannabis but, the 51% among them also wanted to use ‘less cannabis’ in the following year. This wanting is more than any other nationality and reflects awareness of abuse by Indians.
- Tobacco, Alcohol and Cannabis were among the most common drugs used by Indians.
- Drunk Data: Out of almost 1,00,000 respondents from 30 countries worldwide, Indians reported ‘being drunk’ on an average of 41 times in the last one year. They are still behind Australia, Canada, U.K., U.S., and Denmark but well above the global average of 33 times.
- Female Data: Only 6% of female Indians were surveyed who reported seeking ‘emergency medical treatment’ in last one yaer. The global female average for seeking emergency medical treatment was about 13%.
Tags: alcohol • Cannabis • Drug Abuse • GDS 2019 • Global Drug Survey